Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-197404
Filing Date
2026-04-30
Accepted
2026-04-30 16:21:01
Documents
12
Period of Report
2026-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A sepn-20260430.htm   iXBRL DEF 14A 988365
2 GRAPHIC img4741811_0.gif GRAPHIC 48011
  Complete submission text file 0001193125-26-197404.txt   1532122

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sepn-20260430.xsd EX-101.SCH 19066
15 EXTRACTED XBRL INSTANCE DOCUMENT sepn-20260430_htm.xml XML 78093
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42382 | Film No.: 26925786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)